Related Experiment Video
Updated: Sep 30, 2026

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Published on: October 10, 2012
Preventing type 1 diabetes mellitus: the promise of gene therapy
1Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. sefrat@post.tau.ac.il
Abstract:
Type 1 (insulin-dependent) diabetes mellitus is an autoimmune disease that has no cure. Closed-loop insulin administration strategies and approaches for replacement of the insulin-producing beta cells may offer improved treatments, which could delay or prevent diabetes complications. In the long run, however, prevention of type 1 diabetes in susceptible individuals represents the best chance for reducing the toll of the disease. Prevention of type 1 diabetes will require reliable methods for early diagnosis of predisposition to the disease, using improved genetic and serological screening on a wide scale. Identification of the primary antigenic target(s) for autoimmunity will allow intervention in prediabetes stages aimed at the induction of antigen-specific tolerance. In addition to manipulation of the immune system, the susceptibility of beta cells to autoimmunity could be reduced. A number of genes have been shown to increase beta-cell resistance to immune effector molecules in animal models and cultured beta-cell lines. These genes could be used for preventive gene therapy of type 1 diabetes mellitus if expressed in beta cells prior to the onset of autoimmune destruction. This prospect depends on the development of safe and efficient vectors, and approaches for cell-specific targeting of these vectors to beta cells in vivo.
Insights
Preventing type 1 diabetes involves early diagnosis through genetic and serological screening. Future strategies may include antigen-specific tolerance induction and gene therapy to enhance beta-cell resistance to autoimmunity.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes mellitus is an autoimmune disease without a cure, necessitating advanced treatment and prevention strategies.
- Current treatments focus on insulin replacement and beta-cell transplantation, aiming to manage complications but not prevent disease onset.
- Long-term prevention in susceptible individuals is crucial for reducing the disease burden.
Purpose of the Study:
- To explore strategies for the prevention of type 1 diabetes mellitus.
- To identify methods for early diagnosis of disease predisposition.
- To investigate potential interventions targeting autoimmunity and beta-cell susceptibility.
Main Methods:
- Discusses the need for large-scale genetic and serological screening for early diagnosis.
- Highlights the potential of identifying autoantigen targets for antigen-specific tolerance induction.
- Examines the use of gene therapy to enhance beta-cell resistance to autoimmune attack.
Main Results:
- Early diagnosis through genetic and serological screening is essential for prevention.
- Induction of antigen-specific tolerance offers a pathway for intervention in prediabetes.
- Gene therapy using resistance-conferring genes presents a potential preventive approach.
Conclusions:
- Prevention of type 1 diabetes requires early identification of susceptible individuals and targeted interventions.
- Combining immune system modulation with enhanced beta-cell resilience holds promise for future prevention strategies.
- Development of safe gene delivery vectors is critical for translating gene therapy approaches into clinical practice.
Related Concept Videos
Type I Diabetes I: Introduction
Gene Therapy
Gene Therapy
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

